LONDON: AstraZeneca said on Monday its vaccine for the novel coronavirus
, developed along with the University of Oxford, could be around 90% effective under one dosing regimen.
“This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency,” Pascal Soriot, Astra’s chief executive, said in a statement.
The British drugmaker’s preliminary trial results mark a fresh breakthrough in the fight against a pandemic that has killed nearly 1.4 million people and roiled the global economy.
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor
This article is auto-generated by Algorithm Source: www.news18.com
